Approval · Notice of Compliance 1075 · 2000
PREPULSID: Notice of Compliance 1075
Issued February 8, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1075
- Date
- February 8, 2000
- Company
- Janssen PharmaceuticaBeerse, Saone Et Loire, Belgium
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New formulation (new salt - cisapride tartrate)
- Therapeutic class
- Gastrointestinal prokinetic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PREPULSID | 02241510 | — |
| PREPULSID | 02241511 | — |
| PREPULSID | 02241512 | — |
Medicinal ingredients
- CISAPRIDE TARTRATE 5 MG per TAB
- CISAPRIDE TARTRATE 10 MG per TAB
- CISAPRIDE TARTRATE 20 MG per TAB